Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

36 Baseline systemic immune profiles predict prognosis and differential benefit from ipilimumab intensification in relapsed mesothelioma (Bio-IFCT-1501 MAPS2 trial)

  • Julien Mazières1
  • Aurélien Marabelle2
  • Arnaud Scherpereel3
  • Nathalie Chaput4
  • David Planchard5
  • Didier Jean6
  • Gérard Zalcman7
  • Yuna Blum8
  • Laurent Greillier9
  • Sylvie Lantuejoul10
  • Alexandra Langlais11
  • Matthieu Roulleaux Dugage12
3 more authors
  • Guillaume Tosato13
  • Jean Jouniaux14
  • Elodie Amour15
15 affiliations
  1. 1Toulouse University Hospital, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
  2. 2FIG Therapeutics, Valhalla, NY, USA
  3. 3Pneumology and Thoracic Oncology, CHU de Lille, Lille, France
  4. 4Université Paris Saclay, Gustave Roussy, Villejuif, France
  5. 5Universite Paris-Saclay, Gif-sur-Yvette, France
  6. 6Centre de Recherche des Cordeliers, Functional Genomics of Solid Tumors Team, INSERM, Université Paris Cité, Sorbonne Université, Paris, France
  7. 7Université Paris Cité, AP-HP, Hôpital Bichat, Paris, France, France
  8. 83 CIT, Ligue Nationale Contre Le Cancer, Paris, France
  9. 9Department of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique - Hôpitaux de Marseille, Marseille, France
  10. 101Pathology, Centre Léon Bérard, LYON, France
  11. 11Biostatistics, French Cooperative Thoracic Intergroup, Paris, France
  12. 12Gustave Roussy Cancer Campus, Villejuif, France
  13. 13Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France, France
  14. 14Gustave Roussy, Villejuif, France, France
  15. 15Intergroupe Francophone de Cancérologie Thoracique (IFCT), Paris, France, France
Open at sourcePDFDOICite

Related

  1. Oncolytic measles virus reprograms the tumor microenvironment in a vascularized mesothelioma-on-chip model
    Nikita Rajkumari, Mégane Willems, Judith Fresquet +10
    HALPreprintLicence not statedCell biologyHAL
  2. Bioeconomic analysis of ecological intensification innovations in agropastoral systems in western Burkina Faso
    Mahamoudou Koutou, Bruno Barbier, Kalifa Coulibaly +3
    Science et technique - Lettres, Sciences sociales et humainesPeer-reviewedPublisher termsFull textGeneral biologyHAL
  3. Reprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity
    Luigi Cerbone, Alessia Garau, Andrea Balossino +14
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  4. Projected intensification of soil salinization in global drylands under future aridity increase
    Dietian Yu, Nan Wang, Amirhossein Hassani +9
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textEcologyCrossref
  5. A molecular phenotypic map of malignant pleural mesothelioma.
    Alex Di Genova, Lise Mangiante, Alexandra Sexton-Oates +4
    GigaSciencePeer-reviewedCC BYFull text8 citedGeneral biologyOncologyHAL

Cite

BibTeXRIS
BibTeX
@article{mazieres2026baseline,
  title = {{36 Baseline systemic immune profiles predict prognosis and differential benefit from ipilimumab intensification in relapsed mesothelioma (Bio-IFCT-1501 MAPS2 trial)}},
  author = {Julien Mazières and Aurélien Marabelle and Arnaud Scherpereel and Nathalie Chaput and David Planchard and Didier Jean and Gérard Zalcman and Yuna Blum and Laurent Greillier and Sylvie Lantuejoul and Alexandra Langlais and Matthieu Roulleaux Dugage and Guillaume Tosato and Jean Jouniaux and Elodie Amour},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0036},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0036},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 36 Baseline systemic immune profiles predict prognosis and differential benefit from ipilimumab intensification in relapsed mesothelioma (Bio-IFCT-1501 MAPS2 trial)
AU  - Julien Mazières
AU  - Aurélien Marabelle
AU  - Arnaud Scherpereel
AU  - Nathalie Chaput
AU  - David Planchard
AU  - Didier Jean
AU  - Gérard Zalcman
AU  - Yuna Blum
AU  - Laurent Greillier
AU  - Sylvie Lantuejoul
AU  - Alexandra Langlais
AU  - Matthieu Roulleaux Dugage
AU  - Guillaume Tosato
AU  - Jean Jouniaux
AU  - Elodie Amour
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0036
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0036
SN  - 2051-1426
ER  -